Ajanta Pharma gains 3% after strong Q2 results and dividend
pre-market1 source ↓written by the desknot a recommendation
- following its Q2FY26
- 3%
- YoY
- ₹1,353.73 cr
- ₹260.19 cr
- 1
- ₹28/share
- Revenue growth
- 14% YoY
Ajanta Pharma shares rose 3% following its Q2FY26 results, with revenue up 14% YoY to ₹1,353.73 cr and net profit increasing 20% to ₹260.19 cr. The company also declared an interim dividend of ₹28/share (1,400%). This positive performance may enhance investor sentiment in the pharma sector.
• Revenue growth of 14% YoY
• Net profit increased by 20%
• Interim dividend of ₹28/share
Immediate market implications could see continued interest in Ajanta Pharma shares.
Not investment advice. For informational purposes only.